Visualization and Quantitative Evaluation of Aerosol Deposition Using 3D-printed Adult Nose Cavities

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Nov 11

PMID 39524760

Authors

Wei He

Muhan Shi

Yaozhong Lu

Chengsheng Chu

Xiaolong Wang

Min Wang

Xiaofang Zhang

Affiliations

Soon will be listed here.

Abstract

Local steroid medication is one of the most important treatment options for chronic rhinosinusitis. Regional deposition has a higher clinical value compared with total deposition in predicting treatment outcomes or evaluating adverse reactions. The goal of this project is to propose an effective technique for visualizing and quantifying aerosol deposition in a three-dimensional adult nasal cavity, and to verify the practicality of this method. Three-dimensional (3D) nasal cavity models were constructed from computed tomography (CT) scans of one post-operative rhinosinusitis subject using imaging software. The nasal cast was coated with a water-indicating paste and deposited with saline; a liquid dressing was added to visualize the progress. The quantity of liquid dressing was evaluated via HPLC and the liquid deposition was analyzed within the nasal cast cavity. Herein, 98.77 % of the particles generated by the nebulizer were over 5 μm, suggesting that most of the aerosol could effectively enter the nasal cavity instead of the lower respiratory system. The liquid dressing was mainly deposited in the nasal cavity, ethmoid sinus, and frontal sinus according to the visualization tests. HPLC results suggested that the main deposits were the frontal sinus (up to 41.80 %) as well as in the sphenoid sinus and ethmoid sinus (14.00 %). The large particle nebulizer (BM-TCA) generally led to better deposition in sinus areas when compared to the smaller particle nebulizer (PARI). This technology allows for in vitro testing of various types of nasal preparations and equipment under various test methods.

References

Siu J, van Strien J, Campbell R, Roberts P, Tingle M, Inthavong K . Comparison of Sinus Deposition from an Aqueous Nasal Spray and Pressurised MDI in a Post-Endoscopic Sinus Surgery Nasal Replica. Pharm Res. 2022; 39(2):317-327. PMC: 8881262. DOI: 10.1007/s11095-021-03129-2. View

Kaye R, Purewal T, Alpar O . Development and testing of particulate formulations for the nasal delivery of antibodies. J Control Release. 2008; 135(2):127-35. DOI: 10.1016/j.jconrel.2008.11.009. View

Wang C, Lou H, Wang X, Wang Y, Fan E, Li Y . Effect of budesonide transnasal nebulization in patients with eosinophilic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2014; 135(4):922-929.e6. DOI: 10.1016/j.jaci.2014.10.018. View

Al Bakri W, Donovan M, Cueto M, Wu Y, Orekie C, Yang Z . Overview of intranasally delivered peptides: key considerations for pharmaceutical development. Expert Opin Drug Deliv. 2018; 15(10):991-1005. DOI: 10.1080/17425247.2018.1517742. View

Valentine R, Athanasiadis T, Thwin M, Singhal D, Weitzel E, Wormald P . A prospective controlled trial of pulsed nasal nebulizer in maximally dissected cadavers. Am J Rhinol. 2008; 22(4):390-4. DOI: 10.2500/ajr.2008.22.3191. View

Djupesland P . Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review. Drug Deliv Transl Res. 2013; 3(1):42-62. PMC: 3539067. DOI: 10.1007/s13346-012-0108-9. View

Moraga-Espinoza D, Warnken Z, Moore A, Williams 3rd R, Smyth H . A modified USP induction port to characterize nasal spray plume geometry and predict turbinate deposition under flow. Int J Pharm. 2018; 548(1):305-313. DOI: 10.1016/j.ijpharm.2018.06.058. View

Foo M, Cheng Y, Su W, Donovan M . The influence of spray properties on intranasal deposition. J Aerosol Med. 2007; 20(4):495-508. DOI: 10.1089/jam.2007.0638. View

Hughes R, Watterson J, Dickens C, Ward D, Banaszek A . Development of a nasal cast model to test medicinal nasal devices. Proc Inst Mech Eng H. 2008; 222(7):1013-22. DOI: 10.1243/09544119JEIM423. View

10.

Shah S, Berger R, McDermott J, Gupta P, Monteith D, Connor A . Regional deposition of mometasone furoate nasal spray suspension in humans. Allergy Asthma Proc. 2015; 36(1):48-57. DOI: 10.2500/aap.2015.36.3817. View

11.

Schroeter J, Garcia G, Kimbell J . Effects of Surface Smoothness on Inertial Particle Deposition in Human Nasal Models. J Aerosol Sci. 2011; 42(1):52-63. PMC: 3039423. DOI: 10.1016/j.jaerosci.2010.11.002. View

12.

Fokkens W, Lund V, Hopkins C, Hellings P, Kern R, Reitsma S . European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020; 58(Suppl S29):1-464. DOI: 10.4193/Rhin20.600. View

13.

Kissel T, Werner U . Nasal delivery of peptides: an in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium. J Control Release. 1998; 53(1-3):195-203. DOI: 10.1016/s0168-3659(97)00253-8. View

14.

Casale M, Pace A, Moffa A, Vella P, Sabatino L, Lopez M . Post-operative nebulized sodium hyaluronate versus spray after functional endoscopic sinus surgery for chronic rhinosinusitis. J Biol Regul Homeost Agents. 2017; 31(4 Suppl 2):81-89. View

15.

Warnken Z, Smyth H, Davis D, Weitman S, Kuhn J, Williams 3rd R . Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts. Mol Pharm. 2018; 15(4):1392-1402. DOI: 10.1021/acs.molpharmaceut.7b00702. View

16.

Washington N, McGlashan J, Jackson S, Bush D, Pitt K, Rawlins D . The effect of nasal patency on the clearance of radiolabeled saline in healthy volunteers. Pharm Res. 2000; 17(6):733-6. DOI: 10.1023/a:1007590501540. View

17.

Siu J, Shrestha K, Inthavong K, Shang Y, Douglas R . Particle deposition in the paranasal sinuses following endoscopic sinus surgery. Comput Biol Med. 2020; 116:103573. DOI: 10.1016/j.compbiomed.2019.103573. View

18.

Deruyver L, Rigaut C, Lambert P, Haut B, Goole J . The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery. Adv Drug Deliv Rev. 2021; 175:113826. DOI: 10.1016/j.addr.2021.113826. View

19.

Jaijyan D, Selariu A, Cruz-Cosme R, Tong M, Yang S, Stefa A . New intranasal and injectable gene therapy for healthy life extension. Proc Natl Acad Sci U S A. 2022; 119(20):e2121499119. PMC: 9171804. DOI: 10.1073/pnas.2121499119. View

20.

Xi J, Yuan J, Zhang Y, Nevorski D, Wang Z, Zhou Y . Visualization and Quantification of Nasal and Olfactory Deposition in a Sectional Adult Nasal Airway Cast. Pharm Res. 2016; 33(6):1527-41. DOI: 10.1007/s11095-016-1896-2. View